Haematological malignancies

Gene: SAMD9

Green List (high evidence)

SAMD9 (sterile alpha motif domain containing 9, Ensemblv90)
EnsemblGeneIds (GRCh38): ENSG00000205413
EnsemblGeneIds (GRCh37): ENSG00000205413
OMIM: 610456, ClinGen, DECIPHER
SAMD9 is in 1 panel

2 reviews

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

The association between mono-allelic variants and disease is well established. Developmental delay is a feature of MIRAGE syndrome.

Bi-allelic variants: in effect only two families reported (founder variant in 5 Jewish Yemenite families, plus one other). Amber for this association.
Created: 21 Mar 2022, 6:16 p.m. | Last Modified: 21 Mar 2022, 6:16 p.m.
Panel Version: 0.11687

Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Phenotypes
MIRAGE syndrome, MIM#617053; Tumoral calcinosis, familial, normophosphatemic, MIM#610455; Monosomy 7 myelodysplasia and leukemia syndrome 2, MIM# 619041

Samantha Ayres (Victorian Clinical Genetics Services)

Green List (high evidence)

Gain of function listed as disease mechanism in regard to MIRAGE syndrome (AD).
I note that SAMD9 is listed as a green gene on MM gene list (AR)- however there is a review questioning whether there is enough evidence for the AR tumoral calcinosis - based on few cases and only two published variants? These variants are noted to be LOF.
SAMD9 is also included on the ID gene list with no review. I have not come across an association with ID or learning concerns - ? remove from ID gene list
Created: 21 Mar 2022, 1:19 p.m. | Last Modified: 21 Mar 2022, 1:19 p.m.
Panel Version: 0.11659

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
MIRAGE syndrome, MIM#617053; Tumoral calcinosis, familial, normophosphatemic, MIM#610455; Monosomy 7 myelodysplasia and leukemia syndrome 2, MIM#619041

Publications

Details

Mode of Inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Sources
  • Victorian Clinical Genetics Services
  • Expert Review Green
  • Expert Review Green
  • Victorian Clinical Genetics Services
Phenotypes
  • MIRAGE syndrome, MIM#617053
  • Tumoral calcinosis, familial, normophosphatemic, MIM#610455
  • Monosomy 7 myelodysplasia and leukemia syndrome 2, MIM# 619041
OMIM
610456
ClinGen
SAMD9
DECIPHER
SAMD9
Clinvar variants
Variants in SAMD9
Penetrance
None
Publications
Panels with this gene

History Filter Activity

Note: This information shows the history of the gene symbol, not the gene entity. Where the gene symbol for a gene has changed, this history may reference a different gene to the entry you are currently viewing.
17 Mar 2026, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Bryony Thompson (Royal Melbourne Hospital)

gene: SAMD9 was added gene: SAMD9 was added to Haematological malignancies. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: SAMD9 was set to BOTH monoallelic and biallelic, autosomal or pseudoautosomal Publications for gene: SAMD9 were set to 33237688; 32619790; 16960814; 18094730 Phenotypes for gene: SAMD9 were set to MIRAGE syndrome, MIM#617053; Tumoral calcinosis, familial, normophosphatemic, MIM#610455; Monosomy 7 myelodysplasia and leukemia syndrome 2, MIM# 619041